Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Characterization of Tn6349, a novel mosaic transposon carrying poxtA, cfr and other resistance determinants, inserted in the chromosome of an ST5-MRSA-II strain of clinical origin.

D'Andrea MM, Antonelli A, Brenciani A, Di Pilato V, Morroni G, Pollini S, Fioriti S, Giovanetti E, Rossolini GM.

J Antimicrob Chemother. 2019 Oct 1;74(10):2870-2875. doi: 10.1093/jac/dkz278.

PMID:
31355850
2.

In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia.

Ciacci N, Boncompagni S, Valzano F, Cariani L, Aliberti S, Blasi F, Pollini S, Rossolini GM, Pallecchi L.

Antibiotics (Basel). 2019 Jul 25;8(3). pii: E101. doi: 10.3390/antibiotics8030101.

3.

Identification of a Novel Plasmid Lineage Associated With the Dissemination of Metallo-β-Lactamase Genes Among Pseudomonads.

Di Pilato V, Antonelli A, Giani T, Henrici De Angelis L, Rossolini GM, Pollini S.

Front Microbiol. 2019 Jul 2;10:1504. doi: 10.3389/fmicb.2019.01504. eCollection 2019.

4.

Tailored Ag-Cu-Mg multielemental nanoparticles for wide-spectrum antibacterial coating.

Benetti G, Cavaliere E, Brescia R, Salassi S, Ferrando R, Vantomme A, Pallecchi L, Pollini S, Boncompagni S, Fortuni B, Van Bael MJ, Banfi F, Gavioli L.

Nanoscale. 2019 Jan 23;11(4):1626-1635. doi: 10.1039/c8nr08375d.

PMID:
30644952
5.

In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.

Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L.

PLoS One. 2018 Oct 1;13(10):e0203941. doi: 10.1371/journal.pone.0203941. eCollection 2018.

6.

Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug-Resistant Pathogens: Structure-Activity Relationships.

Marzo T, Cirri D, Pollini S, Prato M, Fallani S, Cassetta MI, Novelli A, Rossolini GM, Messori L.

ChemMedChem. 2018 Nov 20;13(22):2448-2454. doi: 10.1002/cmdc.201800498. Epub 2018 Nov 5.

PMID:
30252208
7.

Spectroscopic Characterization of Natural Melanin from a Streptomyces cyaneofuscatus Strain and Comparison with Melanin Enzymatically Synthesized by Tyrosinase and Laccase.

Al Khatib M, Harir M, Costa J, Baratto MC, Schiavo I, Trabalzini L, Pollini S, Rossolini GM, Basosi R, Pogni R.

Molecules. 2018 Aug 1;23(8). pii: E1916. doi: 10.3390/molecules23081916.

8.

In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms.

Pollini S, Boncompagni S, Di Maggio T, Di Pilato V, Spanu T, Fiori B, Blasi F, Aliberti S, Sergio F, Rossolini GM, Pallecchi L.

J Antimicrob Chemother. 2018 Sep 1;73(9):2388-2395. doi: 10.1093/jac/dky185.

9.

Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.

Antonelli A, D'Andrea MM, Brenciani A, Galeotti CL, Morroni G, Pollini S, Varaldo PE, Rossolini GM.

J Antimicrob Chemother. 2018 Jul 1;73(7):1763-1769. doi: 10.1093/jac/dky088.

PMID:
29635422
10.

Chronic infection sustained by a Pseudomonas aeruginosa High-Risk clone producing the VIM-1 metallo-β-lactamase in a cystic fibrosis patient after lung transplantation.

Pollini S, Mugnaioli C, Dolce D, Campana S, Neri AS, Taccetti G, Rossolini GM.

J Cyst Fibros. 2018 Jul;17(4):470-474. doi: 10.1016/j.jcf.2018.01.007. Epub 2018 Feb 12.

PMID:
29444761
11.

Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers.

Giani T, Arena F, Pollini S, Di Pilato V, D'Andrea MM, Henrici De Angelis L, Bassetti M, Rossolini GM; Pseudomonas aeruginosa Working Group.

J Antimicrob Chemother. 2018 Mar 1;73(3):664-671. doi: 10.1093/jac/dkx453.

PMID:
29216350
12.

Isolation and characterization of a novel tyrosinase produced by Sahara soil actinobacteria and immobilization on nylon nanofiber membranes.

Harir M, Bellahcene M, Baratto MC, Pollini S, Rossolini GM, Trabalzini L, Fatarella E, Pogni R.

J Biotechnol. 2018 Jan 10;265:54-64. doi: 10.1016/j.jbiotec.2017.11.004. Epub 2017 Nov 11.

PMID:
29133199
13.

Molecular antibiogram in diagnostic clinical microbiology: advantages and challenges.

Arena F, Giani T, Pollini S, Viaggi B, Pecile P, Rossolini GM.

Future Microbiol. 2017 Apr;12:361-364. doi: 10.2217/fmb-2017-0019. Epub 2017 Mar 31. No abstract available.

14.

Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.

Pollini S, Brunetti J, Sennati S, Rossolini GM, Bracci L, Pini A, Falciani C.

J Pept Sci. 2017 Apr;23(4):329-333. doi: 10.1002/psc.2978. Epub 2017 Feb 8.

PMID:
28176481
15.

Expanding the Repertoire of Carbapenem-Hydrolyzing Metallo-ß-Lactamases by Functional Metagenomic Analysis of Soil Microbiota.

Gudeta DD, Bortolaia V, Pollini S, Docquier JD, Rossolini GM, Amos GC, Wellington EM, Guardabassi L.

Front Microbiol. 2016 Dec 26;7:1985. doi: 10.3389/fmicb.2016.01985. eCollection 2016.

16.

In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate.

Brunetti J, Falciani C, Roscia G, Pollini S, Bindi S, Scali S, Arrieta UC, Gómez-Vallejo V, Quercini L, Ibba E, Prato M, Rossolini GM, Llop J, Bracci L, Pini A.

Sci Rep. 2016 May 12;6:26077. doi: 10.1038/srep26077.

17.

Biochemical Characterization of CPS-1, a Subclass B3 Metallo-β-Lactamase from a Chryseobacterium piscium Soil Isolate.

Gudeta DD, Pollini S, Docquier JD, Bortolaia V, Rossolini GM, Guardabassi L.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1869-73. doi: 10.1128/AAC.01924-15.

18.

Characterization of novel conjugative multiresistance plasmids carrying cfr from linezolid-resistant Staphylococcus epidermidis clinical isolates from Italy.

Brenciani A, Morroni G, Pollini S, Tiberi E, Mingoia M, Varaldo PE, Rossolini GM, Giovanetti E.

J Antimicrob Chemother. 2016 Feb;71(2):307-13. doi: 10.1093/jac/dkv341. Epub 2015 Oct 15.

PMID:
26472766
19.

Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.

Papagiannitsis CC, Pollini S, De Luca F, Rossolini GM, Docquier JD, Hrabák J.

Antimicrob Agents Chemother. 2015 Dec;59(12):7811-4. doi: 10.1128/AAC.01935-15. Epub 2015 Sep 14.

20.

Tn6249, a new Tn6162 transposon derivative carrying a double-integron platform and involved with acquisition of the blaVIM-1 metallo-β-lactamase gene in Pseudomonas aeruginosa.

Di Pilato V, Pollini S, Rossolini GM.

Antimicrob Agents Chemother. 2015 Mar;59(3):1583-7. doi: 10.1128/AAC.04047-14. Epub 2014 Dec 29.

21.

Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.

Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S; Network EuSCAPE-Italy, Grundmann H, Pantosti A, Rossolini GM.

Euro Surveill. 2014 Oct 23;19(42). pii: 20939.

22.

Update on the antibiotic resistance crisis.

Rossolini GM, Arena F, Pecile P, Pollini S.

Curr Opin Pharmacol. 2014 Oct;18:56-60. doi: 10.1016/j.coph.2014.09.006. Epub 2014 Sep 23. Review.

PMID:
25254623
23.

Characterization of plasmid pAX22, encoding VIM-1 metallo-β-lactamase, reveals a new putative mechanism of In70 integron mobilization.

Di Pilato V, Pollini S, Rossolini GM.

J Antimicrob Chemother. 2014 Jan;69(1):67-71. doi: 10.1093/jac/dkt311. Epub 2013 Aug 8.

PMID:
23928025
24.

Acquisition of plasmid-borne blaIMP-19 gene by a VIM-1-positive Pseudomonas aeruginosa of the sequence type 235 epidemic lineage.

Pollini S, Antonelli A, Venturelli C, Maradei S, Veggetti A, Bracco S, Rumpianesi F, Luzzaro F, Rossolini GM.

J Antimicrob Chemother. 2013 Mar;68(3):722-4. doi: 10.1093/jac/dks440. Epub 2012 Nov 14. No abstract available.

PMID:
23152479
25.

FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy.

Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier JD, Rossolini GM.

Antimicrob Agents Chemother. 2013 Jan;57(1):410-6. doi: 10.1128/AAC.01953-12. Epub 2012 Oct 31.

26.

Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens.

Falciani C, Lozzi L, Pollini S, Luca V, Carnicelli V, Brunetti J, Lelli B, Bindi S, Scali S, Di Giulio A, Rossolini GM, Mangoni ML, Bracci L, Pini A.

PLoS One. 2012;7(10):e46259. doi: 10.1371/journal.pone.0046259. Epub 2012 Oct 2.

27.

[Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].

Santella G, Pollini S, Docquier JD, Almuzara M, Gutkind G, Rossolini GM, Radice M.

Rev Panam Salud Publica. 2011 Dec;30(6):545-8. Spanish.

PMID:
22358400
28.

Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin.

Pallecchi L, Riccobono E, Montagnani F, Di Maggio T, Mantengoli E, Pollini S, Rossolini GM.

J Chemother. 2011 Oct;23(5):308-9. No abstract available.

PMID:
22005066
29.

Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype.

Pollini S, Fiscarelli E, Mugnaioli C, Di Pilato V, Ricciotti G, Neri AS, Rossolini GM.

Clin Microbiol Infect. 2011 Aug;17(8):1272-5. doi: 10.1111/j.1469-0691.2011.03466.x. Epub 2011 Mar 7.

30.

Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents.

Rossolini GM, Mantengoli E, Montagnani F, Pollini S.

Curr Opin Microbiol. 2010 Oct;13(5):582-8. doi: 10.1016/j.mib.2010.08.006. Epub 2010 Sep 16. Review.

PMID:
20846900
31.

Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621.

Santella G, Pollini S, Docquier JD, Mereuta AI, Gutkind G, Rossolini GM, Radice M.

J Clin Microbiol. 2010 Nov;48(11):4342-3. doi: 10.1128/JCM.00614-10. Epub 2010 Sep 15. No abstract available.

32.

First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.

Rossolini GM, Luzzaro F, Migliavacca R, Mugnaioli C, Pini B, De Luca F, Perilli M, Pollini S, Spalla M, Amicosante G, Toniolo A, Pagani L.

Antimicrob Agents Chemother. 2008 Nov;52(11):4023-9. doi: 10.1128/AAC.00707-08. Epub 2008 Sep 22.

33.

Teaching cause-effect text structure through social studies content to at-risk second graders.

Williams JP, Nubla-Kung AM, Pollini S, Stafford KB, Garcia A, Snyder AE.

J Learn Disabil. 2007 Mar-Apr;40(2):111-20.

PMID:
17380986
34.

Molecular typing of Staphylococcus aureus isolates from an intensive care unit.

Zanelli G, Pollini S, Sansoni A, Cresti S, Pilli E, Rossolini GM, Cellesi C.

New Microbiol. 2004 Jul;27(3):293-9.

PMID:
15460533
35.

Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy.

Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, Spalla M, Daturi R, Romero E, Rossolini GM.

J Clin Microbiol. 2004 Jun;42(6):2523-9.

36.

Staphylococcus aureus nasal carriage in the community: a survey from central Italy.

Zanelli G, Sansoni A, Zanchi A, Cresti S, Pollini S, Rossolini GM, Cellesi C.

Epidemiol Infect. 2002 Oct;129(2):417-20.

37.

Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance.

Cresti S, Lattanzi M, Zanchi A, Montagnani F, Pollini S, Cellesi C, Rossolini GM.

Antimicrob Agents Chemother. 2002 Jun;46(6):1816-22.

38.

Characterization of OXA-29 from Legionella (Fluoribacter) gormanii: molecular class D beta-lactamase with unusual properties.

Franceschini N, Boschi L, Pollini S, Herman R, Perilli M, Galleni M, Frère JM, Amicosante G, Rossolini GM.

Antimicrob Agents Chemother. 2001 Dec;45(12):3509-16.

Supplemental Content

Loading ...
Support Center